ASRS
MRSN

Arizona State Retirement System’s Mersana Therapeutics MRSN Stock Holding History

Arizona State Retirement System’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-977
Closed -$31K – 2176
2023
Q3 		$31K Buy
977
+58
+6% +$2.76K ﹤0.01% 2166
2023
Q2 		$75.6K Sell
919
-6
-0.6% -$878 ﹤0.01% 2148
2023
Q1 		$95.1K Buy
925
+48
+5% +$6.74K ﹤0.01% 2122
2022
Q4 		$129K Buy
877
+34
+4% +$5.75K ﹤0.01% 2054
2022
Q3 		$143K Buy
843
+24
+3% +$3.9K ﹤0.01% 2011
2022
Q2 		$95K Buy
819
+197
+32% +$18.5K ﹤0.01% 2128
2022
Q1 		$62K Buy
622
+4
+0.6% +$467 ﹤0.01% 2201
2021
Q4 		$96K Buy
618
+12
+2% +$2.33K ﹤0.01% 2219
2021
Q3 		$143K Buy
606
+10
+2% +$2.92K ﹤0.01% 2137
2021
Q2 		$202K Sell
596
-42
-7% -$15.9K ﹤0.01% 2114
2021
Q1 		$258K Buy
638
+3
+0.5% +$1.46K ﹤0.01% 1897
2020
Q4 		$422K Buy
635
+18
+3% +$10K ﹤0.01% 1550
2020
Q3 		$287K Buy
617
+218
+55% +$110K ﹤0.01% 1610
2020
Q2 		$233K Buy
+399
New +$136K ﹤0.01% 1583

Other funds holding MRSN

EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return